As a result of the abovementioned studies, genetic variants at the MTHFR-NPPB locus (mapping on human chromosome 1 and containing both NPPA and NPPB) appeared to act through increased ANP/BNP production to lower blood pressure levels and, consequently, to influence susceptibility to hypertension development. Here, NPPA is linked to hypertensive disorder.